Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
10-2-1|X-Gy 0,n/a|1|45|none (controls)|0|grays|not applicable or not supplied|n/a|43 (0 in ERA)|Mouse|Mouse, SAS/4|Male|Juvenile|observed tumours sacrif.|No information on individuals available for this study
10-2-2|X-Gy 2,n/a|1|45|X-rays whole body|2|grays|External exposure|whole body|50 (0 in ERA)|Mouse|Mouse, SAS/4|Male|Juvenile|observed tumours sacrif.|No information on individuals available for this study
10-2-3|N-Gy 2,n/a|1|45|neutrons <100 keV|2|grays|External exposure|whole body|80 (0 in ERA)|Mouse|Mouse, SAS/4|Male|Juvenile|observed tumours sacrif.|No information on individuals available for this study
